Terms: = Colorectal cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
211 results:
1. A novel lncRNA associated with the prognosis of patients with colorectal cancer resists apoptosis through the LYN/bcl-2 pathway.
An G; Hui J; Zhang W; Fan A; Zhou Y; Zhao X; Lu Y; Wang X
Biochem Biophys Res Commun; 2024 Sep; 723():150177. PubMed ID: 38810320
[TBL] [Abstract] [Full Text] [Related]
2. An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.
Zhou X; Qian Y; Ling C; He Z; Shi P; Gao Y; Sui X
J Transl Med; 2024 Mar; 22(1):321. PubMed ID: 38555418
[TBL] [Abstract] [Full Text] [Related]
3.
Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
[TBL] [Abstract] [Full Text] [Related]
4. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
5. BCL-X
Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
[TBL] [Abstract] [Full Text] [Related]
6. ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma.
Ran L; Mou X; Peng Z; Li X; Li M; Xu D; Yang Z; Sun X; Yin T
Sci Rep; 2023 Nov; 13(1):19477. PubMed ID: 37945707
[TBL] [Abstract] [Full Text] [Related]
7. Feasibility of endoscopic resection and impact of endoscopic ultrasound-based surveillance on colorectal subepithelial tumors.
Park EY; Baek DH; Hong SM; Lee BE; Lee MW; Kim GH; Song GA
Surg Endosc; 2023 Sep; 37(9):6867-6876. PubMed ID: 37311889
[TBL] [Abstract] [Full Text] [Related]
8. Effects of prior endoscopic resection on recurrence in patients with T1 colorectal cancer who underwent radical surgery.
Joo HJ; Seok JU; Kim BC; Lee DE; Kim B; Han KS; Hong CW; Sohn DK; Lee DW; Park SC; Chang HJ; Oh JH
Int J Colorectal Dis; 2023 Jun; 38(1):167. PubMed ID: 37300565
[TBL] [Abstract] [Full Text] [Related]
9. Phosphorylation of bcl-2 by JNK confers gemcitabine resistance in lung cancer cells by reducing autophagy-mediated cell death.
Chiu CH; Ramesh S; Liao PH; Kuo WW; Chen MC; Kuo CH; Li CC; Wang TF; Lin YM; Lin YJ; Huang CY
Environ Toxicol; 2023 Sep; 38(9):2121-2131. PubMed ID: 37219008
[TBL] [Abstract] [Full Text] [Related]
10. pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer.
Tian Z; Wu X; Peng L; Yu N; Gou G; Zuo W; Yang J
Int J Biol Macromol; 2023 Jul; 242(Pt 2):124819. PubMed ID: 37178894
[TBL] [Abstract] [Full Text] [Related]
11. A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer.
Di Fusco D; Di Grazia A; Di Maggio G; Segreto MT; Iannucci A; Maresca C; De Stefano A; Sica G; Stolfi C; Monteleone G; Monteleone I
Cell Death Dis; 2023 Apr; 14(4):243. PubMed ID: 37024466
[TBL] [Abstract] [Full Text] [Related]
12. Immunophenotypic profiles and prognosis for colorectal mucinous adenocarcinomas are dependent on anatomic location.
Patel C; Behring M; Al Diffalha S; Dhall D; Lee G; Shanmugam C; Grizzle WE; Manne U
Cancer Med; 2023 Apr; 12(8):9637-9643. PubMed ID: 36916704
[TBL] [Abstract] [Full Text] [Related]
13. Identification of Key MicroRNAs and Genes between colorectal Adenoma and colorectal cancer via Deep Learning on GEO Databases and Bioinformatics.
Zhang X; Jin M; Liu F; Qu H; Chen C
Contrast Media Mol Imaging; 2023; 2023():6457152. PubMed ID: 36793496
[TBL] [Abstract] [Full Text] [Related]
14. Up-regulation of STRA6 predicts poor prognosis and contributes to oxaliplatin resistance in colorectal cancer.
Yang F; Xu P; Yao S; Li M; Bian Z; Huang Z
Pathol Res Pract; 2023 Mar; 243():154352. PubMed ID: 36758416
[TBL] [Abstract] [Full Text] [Related]
15. LOXL2 reduces 5-FU sensitivity through the Hedgehog/bcl2 signaling pathway in colorectal cancer.
Qiu Z; Qiu S; Mao W; Lin W; Peng Q; Chang H
Exp Biol Med (Maywood); 2023 Mar; 248(6):457-468. PubMed ID: 36573458
[TBL] [Abstract] [Full Text] [Related]
16.
Zou J; Zhang H; Wu Z; Hu W; Zhang T; Xie H; Huang Y; Zhou H
Cancer Biother Radiopharm; 2024 Apr; 39(3):223-235. PubMed ID: 36508261
[No Abstract] [Full Text] [Related]
17. The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review.
Gao W; Yuan Z; Zhao X; Wang S; Lai S; Ni K; Zhan Y; Liu Z; Liu L; Xin R; Yin X; Zhou X; Liu X; Zhang X; Zhang Q; Li G; Wang W; Zhang C
Expert Rev Mol Diagn; 2022 Aug; 22(8):811-819. PubMed ID: 36111690
[TBL] [Abstract] [Full Text] [Related]
18. The Expression Pattern of bcl-2 and Bax in the Tumor and Stromal Cells in colorectal Carcinoma.
Kunac N; Filipović N; Kostić S; Vukojević K
Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013602
[No Abstract] [Full Text] [Related]
19. Prognostic value of combining E-cadherin, p53, bcl-2 and Bcl-xL expression and survival in Tunisian colorectal adenocarcinoma patients.
Jamai D; Kallel I; Mekrezi S; Walha M; Gharsallah M; Khabir A; Selmi B
Cell Mol Biol (Noisy-le-grand); 2022 Apr; 68(4):93-107. PubMed ID: 35988276
[TBL] [Abstract] [Full Text] [Related]
20. Saikosaponin B4 Suppression cancer Progression by Inhibiting SW480 and SW620 Cells Proliferation via the PI3K/AKT/mTOR Pathway in Colon cancer.
Zhang Y; Lin L; Wang Y; Liu Z; Xia W; Sui H; Fu X
Curr Cancer Drug Targets; 2022; 22(11):889-903. PubMed ID: 35762543
[TBL] [Abstract] [Full Text] [Related]
[Next]
